Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model.

Oral GLP-1 breakthrough in metabolic disease treatment
Discover how Poolbeg Pharma is revolutionizing the delivery of GLP-1R agonists to combat metabolic diseases like diabetes and obesity on a global scale.